Normal view MARC view ISBD view

[Pharmacologic effects of 3-O-methylepinephrine]. [electronic resource]

By:

Fregnan, G B

Producer: 19690529Description: 53-60 p. digitalISSN:

0430-0912

Subject(s):

In: Il Farmaco; edizione pratica vol. 24

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Previous

Back to results

Next

1
2
3
4
5
6
7
8
9

1 Topoisomerase II poisoning by indazole and imidazole complexes of ruthenium.
by Vashisht Gopal, Y N
2 Combinatorial determination of sequence specificity for nanomolar DNA-binding hairpin polyamides.
by Vashisht Gopal, Y N
3 Topoisomerase II antagonism and anticancer activity of coordinated derivatives of [RuCl(2)(C(6)H(6))(dmso)].
by Vashisht Gopal, Y N
4 Topoisomerase II poisoning and antineoplastic action by DNA-nonbinding diacetyl and dicarboxaldoxime derivatives of ferrocene.
by Vashisht Gopal, Y N
5 Tumour necrosis factor-alpha depletes histone deacetylase 1 protein through IKK2.
by Vashisht Gopal, Y N
6 Constitutive and inducible nuclear factor-kappaB in immortalized normal human bronchial epithelial and non-small cell lung cancer cell lines.
by Baby, Johnson
7 Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications.
by Fischer, Grant M
8 A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma.
by Vashisht Gopal, Y N
9 Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases.
by Fischer, Grant M

Close